Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

21 Mar 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 21, 2023 titled ‘Zydus granted Orphan Drug Designation by the USFDA for ZYIL1 in treatment of patients with Cryopyrin Associated Periodic Syndrome (CAPS)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1906.40
Dr. Reddys Labs. 1377.25
Cipla 1399.00
Lupin 2006.40
Zydus Lifesciences 1205.00
View more..